Results 161 to 170 of about 640,820 (294)
Predictive Ability of Plasma p‐tau217 for β‐Amyloid Status: A Prospective Multicenter Study
ABSTRACT Objective Plasma tau phosphorylated at threonine 217 (p‐tau217) measured with fully automated platforms has shown high accuracy for Alzheimer's disease (AD) diagnosis, but real‐world multicenter data remain limited. We aimed to validate the diagnostic performance of p‐tau217 for identifying AD pathology in a real‐world multicenter cohort ...
Miquel Massons +33 more
wiley +1 more source
Grand challenge: building a digitally enabled one health future for pediatric infectious diseases. [PDF]
Zama D.
europepmc +1 more source
application/pdfA set of 10 documents provided by the Kansas Department of Health and Environment with resources and information on the investigation and reporting of infectious diseases.Infectious Diseases: Equal Opportunity to Infect (2012?) KDHE Update
Kansas. Department of Health and Environment.
core
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Children with Disabilities and Chronic Diseases: Perspectives, Challenges, and Opportunities: A Guest Editorial for the Article Collection. [PDF]
Abuhammad S.
europepmc +1 more source
ABSTRACT Objective This study aimed to investigate the immunological response to influenza vaccination, the incidence and severity of influenza infection, and the side effects of the vaccination in patients with ischemic stroke. Methods This prospective observational study was conducted between 2023 and 2024 at Ramathibodi Hospital.
Achiraya Pakngao +5 more
wiley +1 more source
Clasen et al. respond to "Thyroid autoimmunity in the TEDDY cohort: is HLA 8.1 haplotype the hidden driver?" [PDF]
Clasen JL, Parikh HM, Hagopian WA.
europepmc +1 more source
Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket +14 more
wiley +1 more source
Child and Adolescent Life in Health and Disease [PDF]
openaire +3 more sources
ERS Congress 2025: highlights from the Paediatrics Assembly. [PDF]
Patel D +5 more
europepmc +1 more source

